ArticleTransplantation direct2024

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study.

Vojtech Petr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.